SCOPUS 정보 검색 플랫폼

Korean Journal of Internal Medicine

Volumn 22, Issue 1, 2007, Pages 37-39

Use of tadalafil for treating pulmonary arterial hypertension secondary to chronic obstructive pulmonary disease

(5) Kim, Hyun Sook a Park, Jae Hyeong a Park, Seoung Ju a Park, Jong Kwan a Lee, Heung Bum a

a Chonbuk National University Medical School (South Korea)

Author keywords

Pulmonary heart disease; Tadalafil

Indexed keywords

TADALAFIL; CARBOLINE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG DOSE INCREASE; DYSPNEA; ECHOCARDIOGRAPHY; EDEMA; EXERCISE; HEART RIGHT VENTRICLE PERFORMANCE; HEMODYNAMICS; HUMAN; MALE; MYALGIA; OXYGEN CONSUMPTION; PULMONARY HYPERTENSION; SURVIVAL RATE; TRICUSPID VALVE REGURGITATION; DRUG EFFECT; EXERCISE TOLERANCE; MIDDLE AGED; PATHOLOGY; PULMONARY ARTERY;

CARBOLINES; EXERCISE TOLERANCE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PHOSPHODIESTERASE INHIBITORS; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 34248597264 PISSN: 12263303 EISSN: 20056648 Source Type: Journal
DOI: 10.3904/kjim.2007.22.1.37 Document Type: Article

Times cited : (6)

References (5)

1
- 0242349756
- Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension
- Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang S, Modry D, Archer SL. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 108:2066-2069, 2003
- (2003) Circulation , vol.108 , pp. 2066-2069
- Michelakis, E.D.¹ Tymchak, W.² Noga, M.³ Webster, L.⁴ Wu, X.C.⁵ Lien, D.⁶ Wang, S.⁷ Modry, D.⁸ Archer, S.L.⁹

2
- 0037152092
- Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial
- Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, Gunther A, Walmrath D, Seeger W, Grimminger F. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 360:895-900, 2002
- (2002) Lancet , vol.360 , pp. 895-900
- Ghofrani, H.A.¹ Wiedemann, R.² Rose, F.³ Schermuly, R.T.⁴ Olschewski, H.⁵ Weissmann, N.⁶ Gunther, A.⁷ Walmrath, D.⁸ Seeger, W.⁹ Grimminger, F.¹⁰

3
- 4644232338
- Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: A randomized prospective study
- Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadas B, Schermuly RT, Weissmann N, Seeger W, Grimminger F. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. J Am Coll Cardiol 44:1488-1496, 2004
- (2004) J Am Coll Cardiol , vol.44 , pp. 1488-1496
- Ghofrani, H.A.¹ Voswinckel, R.² Reichenberger, F.³ Olschewski, H.⁴ Haredza, P.⁵ Karadas, B.⁶ Schermuly, R.T.⁷ Weissmann, N.⁸ Seeger, W.⁹ Grimminger, F.¹⁰

4
- 0036783940
- Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses
- Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, Anglin G, Whitaker S. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 168:1332-1336, 2002
- (2002) J Urol , vol.168 , pp. 1332-1336
- Brock, G.B.¹ McMahon, C.G.² Chen, K.K.³ Costigan, T.⁴ Shen, W.⁵ Watkins, V.⁶ Anglin, G.⁷ Whitaker, S.⁸

5
- 7244247157
- Tadalafil in primary pulmonary arterial hypertension
- Palmieri EA, Affuso F, Fazio S, Lembo D. Tadalafil in primary pulmonary arterial hypertension. Ann Intern Med 141:743-744, 2004
- (2004) Ann Intern Med , vol.141 , pp. 743-744
- Palmieri, E.A.¹ Affuso, F.² Fazio, S.³ Lembo, D.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.